Biotechnological applications of bacteriophages: state of the art

Detalhes bibliográficos
Autor(a) principal: Harada, Liliam K.
Data de Publicação: 2018
Outros Autores: Silva, Erica C., Campos, Welida F., Del Fiol, Fernando S., Vila, Marta M. D. C., Dabrowska, Krystyna, Krylov, Victor N., Balcão, Victor M.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/1822/54758
Resumo: Bacteriophage particles are the most abundant biological entities on our planet, infecting specific bacterial hosts in every known environment and being major drivers of bacterial adaptive evolution. The study of bacteriophage particles potentially sheds light on the development of new biotechnology products. Bacteriophage therapy, although not new, makes use of strictly lytic phage particles as an alternative in the antimicrobial treatment of resistant bacterial infections and is being rediscovered as a safe method due to the fact that these biological entities devoid of any metabolic machinery do not have affinity to eukaryotic cells. Furthermore, bacteriophage-based vaccination is emerging as one of the most promising preventive strategies. This review paper discusses the biological nature of bacteriophage particles, their mode(s) of action and potential exploitation in modern biotechnology. Topics covered in detail include the potential of bacteriophage particles in human infections (bacteriophage therapy), nanocages for gene delivery, food biopreservation and safety, biocontrol of plant pathogens, phage display, bacterial biosensing devices, vaccines and vaccine carriers, biofilm and bacterial growth control, surface disinfection, corrosion control, together with structural and functional stabilization issues.
id RCAP_d89c040ef18378c9c3c42487dc61c7c6
oai_identifier_str oai:repositorium.sdum.uminho.pt:1822/54758
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Biotechnological applications of bacteriophages: state of the artBacteriophagesPhage therapyPhage displayBacterial biosensingVaccine carriersGene deliveryFood biopreservation and safetyBiofilm controlSurface disinfectionCorrosion controlStructural and functional stabilizationScience & TechnologyBacteriophage particles are the most abundant biological entities on our planet, infecting specific bacterial hosts in every known environment and being major drivers of bacterial adaptive evolution. The study of bacteriophage particles potentially sheds light on the development of new biotechnology products. Bacteriophage therapy, although not new, makes use of strictly lytic phage particles as an alternative in the antimicrobial treatment of resistant bacterial infections and is being rediscovered as a safe method due to the fact that these biological entities devoid of any metabolic machinery do not have affinity to eukaryotic cells. Furthermore, bacteriophage-based vaccination is emerging as one of the most promising preventive strategies. This review paper discusses the biological nature of bacteriophage particles, their mode(s) of action and potential exploitation in modern biotechnology. Topics covered in detail include the potential of bacteriophage particles in human infections (bacteriophage therapy), nanocages for gene delivery, food biopreservation and safety, biocontrol of plant pathogens, phage display, bacterial biosensing devices, vaccines and vaccine carriers, biofilm and bacterial growth control, surface disinfection, corrosion control, together with structural and functional stabilization issues.Project funding by Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP, São Paulo, Brazil) (FAPESP Refs. No. 2016/08884- 3 (Project PneumoPhageColor) and 2016/12234-4 (Project TransAppIL)), is hereby gratefully acknowledged. Funding by Fundação de Amparo à Pesquisa do Estado de São Paulo(FAPESP Ref. No. 2016/ 16641-3) in the form of an M.Sc. fellowship granted to Liliam Harada is hereby gratefully acknowledged. This work also received support from CNPq, National Council for Scientific and Technological Development Brazil, in the form of Research Productivity (PQ) fellowships granted to Victor M. Balcão (Refs. No. 306113/2014-7 and 308208/2017-0). Financial support to Krystyna Dąbrowska by the National Science Centre in Poland (Grant UMO-2012/05/E/NZ6/03314) is also gratefully acknowledged. The authors have no conflicts of interest whatsoever to declare.info:eu-repo/semantics/publishedVersionElsevierUniversidade do MinhoHarada, Liliam K.Silva, Erica C.Campos, Welida F.Del Fiol, Fernando S.Vila, Marta M. D. C.Dabrowska, KrystynaKrylov, Victor N.Balcão, Victor M.20182018-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/1822/54758engHarada, Liliam K.; Silva, Erica C.; Campos, Welida F.; Del Fiol, Fernando S.; Vila, Marta; Dabrowska, Krystyna; Krylov, Victor N.; Balcão, Victor M., Biotechnological applications of bacteriophages: State of the art. Microbiological Research, 212-213, 38-58, 20180944-50130944-501310.1016/j.micres.2018.04.00729853167https://www.journals.elsevier.com/microbiological-researchinfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-05-11T07:38:50Zoai:repositorium.sdum.uminho.pt:1822/54758Portal AgregadorONGhttps://www.rcaap.pt/oai/openairemluisa.alvim@gmail.comopendoar:71602024-05-11T07:38:50Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Biotechnological applications of bacteriophages: state of the art
title Biotechnological applications of bacteriophages: state of the art
spellingShingle Biotechnological applications of bacteriophages: state of the art
Harada, Liliam K.
Bacteriophages
Phage therapy
Phage display
Bacterial biosensing
Vaccine carriers
Gene delivery
Food biopreservation and safety
Biofilm control
Surface disinfection
Corrosion control
Structural and functional stabilization
Science & Technology
title_short Biotechnological applications of bacteriophages: state of the art
title_full Biotechnological applications of bacteriophages: state of the art
title_fullStr Biotechnological applications of bacteriophages: state of the art
title_full_unstemmed Biotechnological applications of bacteriophages: state of the art
title_sort Biotechnological applications of bacteriophages: state of the art
author Harada, Liliam K.
author_facet Harada, Liliam K.
Silva, Erica C.
Campos, Welida F.
Del Fiol, Fernando S.
Vila, Marta M. D. C.
Dabrowska, Krystyna
Krylov, Victor N.
Balcão, Victor M.
author_role author
author2 Silva, Erica C.
Campos, Welida F.
Del Fiol, Fernando S.
Vila, Marta M. D. C.
Dabrowska, Krystyna
Krylov, Victor N.
Balcão, Victor M.
author2_role author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade do Minho
dc.contributor.author.fl_str_mv Harada, Liliam K.
Silva, Erica C.
Campos, Welida F.
Del Fiol, Fernando S.
Vila, Marta M. D. C.
Dabrowska, Krystyna
Krylov, Victor N.
Balcão, Victor M.
dc.subject.por.fl_str_mv Bacteriophages
Phage therapy
Phage display
Bacterial biosensing
Vaccine carriers
Gene delivery
Food biopreservation and safety
Biofilm control
Surface disinfection
Corrosion control
Structural and functional stabilization
Science & Technology
topic Bacteriophages
Phage therapy
Phage display
Bacterial biosensing
Vaccine carriers
Gene delivery
Food biopreservation and safety
Biofilm control
Surface disinfection
Corrosion control
Structural and functional stabilization
Science & Technology
description Bacteriophage particles are the most abundant biological entities on our planet, infecting specific bacterial hosts in every known environment and being major drivers of bacterial adaptive evolution. The study of bacteriophage particles potentially sheds light on the development of new biotechnology products. Bacteriophage therapy, although not new, makes use of strictly lytic phage particles as an alternative in the antimicrobial treatment of resistant bacterial infections and is being rediscovered as a safe method due to the fact that these biological entities devoid of any metabolic machinery do not have affinity to eukaryotic cells. Furthermore, bacteriophage-based vaccination is emerging as one of the most promising preventive strategies. This review paper discusses the biological nature of bacteriophage particles, their mode(s) of action and potential exploitation in modern biotechnology. Topics covered in detail include the potential of bacteriophage particles in human infections (bacteriophage therapy), nanocages for gene delivery, food biopreservation and safety, biocontrol of plant pathogens, phage display, bacterial biosensing devices, vaccines and vaccine carriers, biofilm and bacterial growth control, surface disinfection, corrosion control, together with structural and functional stabilization issues.
publishDate 2018
dc.date.none.fl_str_mv 2018
2018-01-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/1822/54758
url http://hdl.handle.net/1822/54758
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Harada, Liliam K.; Silva, Erica C.; Campos, Welida F.; Del Fiol, Fernando S.; Vila, Marta; Dabrowska, Krystyna; Krylov, Victor N.; Balcão, Victor M., Biotechnological applications of bacteriophages: State of the art. Microbiological Research, 212-213, 38-58, 2018
0944-5013
0944-5013
10.1016/j.micres.2018.04.007
29853167
https://www.journals.elsevier.com/microbiological-research
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Elsevier
publisher.none.fl_str_mv Elsevier
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv mluisa.alvim@gmail.com
_version_ 1817545389756121088